SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein

Abstract Pilomatricomas are benign tumors originating from the capillary matrix, which may

SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein-Taybi syndrome^, Multiple pilomatricomas in twins with Rubinstein-Taybi syndrome^,

Multiple pilomatricomas in twins with Rubinstein-Taybi syndrome

Pembrolizumab plus axitinib versus sunitinib in metastatic renal cell carcinoma: outcomes of Japanese patients enrolled in the randomized, phase III, open-label KEYNOTE-426 study

Effects of CYP2C19*17 Genetic Polymorphisms on the Steady-State Concentration of Diazepam in Patients With Alcohol Withdrawal Syndrome - Valentin Yurievich Skryabin, Mikhail Zastrozhin, Marco Torrado, Elena Grishina, Kristina Ryzhikova, Valery

Current ConCepts in Dermatology

Recurrent MET fusion genes represent a drug target in pediatric glioblastoma

Demonstrated Clinical Efficacy with NINLARO® (ixazomib)

Targeted two-photon chemical apoptotic ablation of defined cell types in vivo

LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice

Cellular, molecular, and therapeutic characterization of pilocarpine-induced temporal lobe epilepsy

Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US

Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US